Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors

NCT03068832 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Made the decision to not go forward with the study

Conditions

Pediatric Brain Tumor

Interventions

BIOLOGICAL: Personalized peptide vaccine
DRUG: Poly ICLC
PROCEDURE: Peripheral blood draw

Sponsor

Washington University School of Medicine